Neuroone Medical Technologies is trading 6.1% up at $1.02, alongside a broader market rebound rather than a confirmed company-specific catalyst. - The Nasdaq and S&P 500 were higher; Reuters reported technology shares rebounding as oil prices and Treasury yields eased. - No fresh company-specific catalyst for October 19 was identified. The recent fiscal 2026 revenue update and NIH research-grant announcement predate this session.